Corrao et al., 2021 Corrao, S., Pinelli, K., Vacca, M., Raspanti, M., &Argano, C. (2021).
Type 2 Diabetes Mellitus and COVID-19: A Narrative Review.
Frontiers in endocrinology, 12, 609470. https://doi.org/10.3389/fendo.2021.609470
Costela-Ruiz et al., 2020 Costela-Ruiz, V. J., Illescas-Montes, R., Puerta-Puerta, J. M., Ruiz, C., &Melguizo-Rodríguez, L. (2020).
SARS-CoV-2 infection: The role of cytokines in COVID-19 disease.
Cytokine & growth factor reviews, 54, 62–75. https://doi.org/10.1016/j.cytogfr.2020.06.001
Chen et al., 2021 Chen LYC, Hoiland RL, Stukas S, Wellington CL, Sekhon MS.
Assessing the importance of interleukin-6 in COVID-19.
The Lancet Respiratory Medicine. 2021;9(2):e13. doi:10.1016/S2213-2600(20)30600-7
Indian Council of Medical Research, 2021
Clinical Guidance for Management of Adult Covid-19 Patients.
June 2021. https://www.icmr.gov.in/pdf/covid/techdoc/COVID_Management_Algorithm_17052021.pdf. Accessed June 15,
Parr, 2021 Parr JB.
Time to Reassess Tocilizumab’s Role in COVID-19 Pneumonia.
JAMA Intern Med. 2021;181:12. doi: 10.1001/jamainternmed.2020.6557.
Horby et al., 2021 Horby, P., Lim, W. S., Emberson, J. R., Mafham, M., Bell, J. L., Linsell, L., Staplin, N., Brightling, C., Ustianowski, A., Elmahi, E., Prudon, B., Green, C., Felton, T., Chadwick, D., Rege, K., Fegan, C., Chappell, L. C., Faust, S. N., Jaki, T., … Landray, M. J. (2021).
Dexamethasone in Hospitalized Patients with Covid-19.
The New England journal of medicine, 384(8), 693–704. https://doi.org/10.1056/NEJMoa2021436
Sosale et al., 2021 Sosale, A., Sosale, B., Kesavadev, J., Chawla, M., Reddy, S., Saboo, B., &Misra, A. (2021).
Steroid use during COVID-19 infection and hyperglycemia - What a physician should know.
Diabetes & metabolic syndrome, 15(4), 102167. https://doi.org/10.1016/j.dsx.2021.06.004
Wen et al., 2022 Wen W, Chen C, Tang J, Wang C, Zhou M, Cheng Y, Zhou X, Wu Q, Zhang X, Feng Z, Wang M, Mao Q. (2022)
Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID- 19:Ameta-analysis.
Ann Med. 2022 Dec;54(1):516-523. doi: 10.1080/07853890.2022.2034936. PMID: 35118917;
Thottapillil et al., 2021 Thottapillil, A., Kouser, S., Kukkupuni, S. K., &Vishnuprasad, C. N. (2021).
An 'Ayurveda-Biology' platform for integrative diabetes management.
Journal of ethnopharmacology, 268, 113575. https://doi.org/10.1016/j.jep.2020.113575
Rastogi et al., 2022 Rastogi, S., Pandey, D. N., & Singh, R. H. (2022).
COVID-19 pandemic: A pragmatic plan for ayurveda intervention.
Journal of Ayurveda and integrative medicine, 13(1), 100312. https://doi.org/10.1016/j.jaim.2020.04.002
Girija & Sivan, 2020 Girija PLT, Sivan N (2020)
Ayurvedic treatment of COVID-19/SARS-CoV-2: A case report.
Journal of Ayurveda and Integrative Medicine. 2020:S0975947620300425. doi:10.1016/j.jaim.2020.06.001
Joshi & Puthiyedath, 2020 Joshi JA, Puthiyedath R.
Outcomes of Ayurvedic care in a COVID-19 patient with hypoxia – A case report.
Journal of Ayurveda and Integrative Medicine. 2020:S0975947620300966. doi:10.1016/j.jaim.2020.10.006
Shah et al., 2020 Shah, S. J., Barish, P. N., Prasad, P. A., Kistler, A., Neff, N., Kamm, J., Li, L. M., Chiu, C. Y., Babik, J. M., Fang, M. C., Abe-Jones, Y., Alipanah, N., Alvarez, F. N., Botvinnik, O. B., Castaneda, G., CZB CLIAhub Consortium, Dadasovich, R. M., Davis, J., Deng, X., DeRisi, J. L., … Langelier, C. (2020).
Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.
EClinicalMedicine, 27, 100518. https://doi.org/10.1016/j.eclinm.2020.100518
Dube et al., 1983 Dube KC, Kumar A, Dube S (1983)
Personality Types in Ayurveda.
Am J Chin Med. 11(01n04):25-34. doi:10.1142/S0192415X83000069
Shahriatpanahi et al., 2013 VahdatShariatpanahi, Z., Mokhtari, M., Taleban, F. A., Alavi, F., SalehiSurmaghi, M. H., Mehrabi, Y., &Shahbazi, S. (2013).
Effect of enteral feeding with ginger extract in acute respiratory distress syndrome.
Journal of critical care, 28(2), 217.e1–217.e2176. https://doi.org/10.1016/j.jcrc.2012.04.017
Phosat et al., 2017 Phosat, C., Panprathip, P., Chumpathat, N., Prangthip, P., Chantratita, N., Soonthornworasiri, N., Puduang, S., &Kwanbunjan, K. (2017).
Elevated C-reactive protein, interleukin 6, tumor necrosis factor alpha and glycemic load associated with type 2 diabetes mellitus in rural Thais: a cross-sectional study.
BMC endocrine disorders, 17(1), 44. https://doi.org/10.1186/s12902-017-0189-z
Chen et al., 2020 Chen LYC, Hoiland RL, Stukas S, Wellington CL, Sekhon MS (2020)
Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome.
EurRespir J. 2020;56(4):2003006. doi:10.1183/13993003.03006-2020
Ford, 1999 Ford E. S. (1999).
Body mass index, diabetes, and C-reactive protein among U.S. adults.
Diabetes care, 22(12), 1971–1977. https://doi.org/10.2337/diacare.22.12.1971
Furst et al., 2011 Furst, D. E., Venkatraman, M. M., Krishna Swamy, B. G., McGann, M., Booth-Laforce, C., Ram Manohar, P., Sarin, R., Mahapatra, A., & Krishna Kumar, P. R. (2011).
Well controlled, double-blind, placebo-controlled trials of classical Ayurvedic treatment are possible in rheumatoid arthritis.
Annals of the rheumatic diseases, 70(2), 392–393. https://doi.org/10.1136/ard.2010.136226
World Health Organization. Programme on Traditional Medicine, 2000World Health Organization. Programme on Traditional Medicine. (2000).
General guidelines for methodologies on research and evaluation of traditional medicine.
World Health Organization. https://apps.who.int/iris/handle/10665/66783
Government of India, Ministry of Health & Family Welfare, 2020 Government of India, Ministry of Health & Family Welfare, Directorate General of Health Services (EMR Division) (2020)
Revised Guidelines on Clinical Management of COVID–19
https://www.mohfw.gov.in/pdf/RevisedNationalClinicalManagementGuidelineforCOVID1931032020.pdf
Natarajan et al., 2020 S. Natarajan, C. Anbarasi, P. Sathiyarajeswaran, P. Manickam, S. Geetha, R. Kathiravan, P. Prathiba, M. Pitchiahkumar, P. Parthiban, K. Kanakavalli& P. Balaji. (2020)
The efficacy of Siddha Medicine, KabasuraKudineer (KSK) compared to Vitamin C & Zinc (CZ) supplementation in the management of asymptomatic COVID-19 cases: A structured summary of a study protocol for a randomised controlled trial
Trials. 2020;21(1):892. doi:10.1186/s13063-020-04823-z
Sayah et al., 2021Sayah, W., Berkane, I., Guermache, I., Sabri, M., Lakhal, F. Z., YasmineRahali, S., Djidjeli, A., LamaraMahammed, L., Merah, F., Belaid, B., Berkani, L., Lazli, N. Z., Kheddouci, L., Kadi, A., Ouali, M., Khellafi, R., Mekideche, D., Kheliouen, A., Hamidi, R. M., Ayoub, S., … Djidjik, R. (2021).
Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19.
Cytokine, 141, 155428. https://doi.org/10.1016/j.cyto.2021.155428
Zhu et al., 2020 Zhu J, Pang J, Ji P, Zhong Z, Li H, Li B, Zhang J(2020).
Elevated interleukin-6 is associated with severity of COVID- 19: A meta-analysis.
J Med Virol. 2021 Jan;93(1):35-37. doi: 10.1002/jmv.26085. Epub 2020 Oct 30. PMID: 32470146; PMCID: PMC7283812.
Jones et al., 1999 Jones SA, Novick D, Horiuchi S, Yamamoto N, Szalai AJ, Fuller GM(1999).
C-reactive protein: a physiological activator of interleukin 6 receptor shedding.
J Exp Med. 1;189(3):599-604. doi: 10.1084/jem.189.3.599.
Sproston et al., 2018 Sproston, N. R., & Ashworth, J. J. (2018).
Role of C-Reactive Protein at Sites of Inflammation and Infection.
Frontiers in immunology, 9, 754. https://doi.org/10.3389/fimmu.2018.00754
Gómez-Rial et al., 2020 Gómez-Rial, J., Rivero-Calle, I., Salas, A., &Martinón-Torres, F. (2020).
Role of Monocytes/Macrophages in Covid-19 Pathogenesis: Implications for Therapy.
Infection and drug resistance, 13, 2485–2493. https://doi.org/10.2147/IDR.S258639
Merad & Martin, 2020 Merad, M., Martin, J.C(2020).
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages.
Nat Rev Immunol 20, 355–362. https://doi.org/10.1038/s41577-020-0331-4
Kany et al., 2019 Kany S, Vollrath JT, Relja B (2020).
Cytokines in Inflammatory Disease.
Int J Mol Sci. 28;20(23):6008. doi: 10.3390/ijms20236008. PMID: 31795299; PMCID: PMC6929211.
Rais et al., 2022 Rais, A., Negi, D. S., Yadav, A., Arya, H., Verma, R., Galib, R., Ahmad, A., Kumar Yadav, M., &Ahirwar, P. N. (2022).
A randomized open label parallel group pilot study to evaluate efficacy of Ayurveda interventions in the management of asymptomatic and mild COVID-19 patients-experiences of a Lucknow based level 2 hospital of Uttar Pradesh, India.
Journal of Ayurveda and integrative medicine, 13(2), 100393. https://doi.org/10.1016/j.jaim.2020.12.013
Devpura et al., 2021 Devpura, G., Tomar, B. S., Nathiya, D., Sharma, A., Bhandari, D., Haldar, S., Balkrishna, A., &Varshney, A. (2021).
Randomized placebo-controlled pilot clinical trial on the efficacy of ayurvedic treatment regime on COVID-19 positive patients.
Phytomedicine : international journal of phytotherapy and phytopharmacology, 84, 153494. https://doi.org/10.1016/j.phymed.2021.153494
Akhila, 2022 Akhila V. G. (2022).
Management of SannipataJwaraw.s.r to COVID-19 - Case report.
Journal of Ayurveda and integrative medicine, 13(1), 100416. https://doi.org/10.1016/j.jaim.2021.02.007
Rastogi et al., 2022 Rastogi, S., Rastogi, R., &Kharbanda, A. (2022).
Time when a physician turned out to be a patient: A case study on how an Ayurvedic physician cured himself from COVID-19.
Journal of Ayurveda and integrative medicine, 13(1), 100411. https://doi.org/10.1016/j.jaim.2021.02.002
Rastogi, 2022 Rastogi S. (2022).
Ayurveda co-interventions have supported complete recovery in severe COVID-19 infection with a chest severity score 18/25: A case report.
Journal of Ayurveda and integrative medicine, 13(2), 100417. https://doi.org/10.1016/j.jaim.2021.02.008
Chen et al., 2020 Chen, Xiaoping & Hu, Wenjia& Ling, Jiaxin& Mo, Pingzheng& Zhang, Yongxi& Jiang, Qunqun& Ma, Zhiyong& Cao, Qian& Deng, Liping& Song, Shihui&Zheng, Ruiying&Gao, Shicheng&Ke, Hengning&Gui, Xien&Lundkvist, Åke& Li, Jinlin&Lindahl, Johanna &Xiong, Yong. (2020).
Hypertension and Diabetes Delay the Viral Clearance in COVID-19 Patients. 10.1101/2020.03.22.20040774.
Lim et al., 2021 Lim, S., Bae, J. H., Kwon, H. S., &Nauck, M. A. (2021).
COVID-19 and diabetes mellitus: from pathophysiology to clinical management.
Nature reviews. Endocrinology, 17(1), 11–30. https://doi.org/10.1038/s41574-020-00435-4
Sannegowda et al., 2015 Sannegowda, K. M., Venkatesha, S. H., &Moudgil, K. D. (2015).
Tinosporacordifolia inhibits autoimmune arthritis by regulating key immune mediators of inflammation and bone damage.
International journal of immunopathology and pharmacology, 28(4), 521–531. https://doi.org/10.1177/0394632015608248
More & Pai, 2017 More, P., &Pai, K. (2017).
Effect of Tinosporacordifolia (Guduchi) on the phagocytic and pinocytic activity of murine macrophages in vitro.
Indian journal of experimental biology, 55(1), 21–26.
Banerjee et al., 20202 Banerjee, A., Czinn, S. J., Reiter, R. J., & Blanchard, T. G. (2020).
Crosstalk between endoplasmic reticulum stress and anti-viral activities: A novel therapeutic target for COVID-19.
Life sciences, 255, 117842. https://doi.org/10.1016/j.lfs.2020.117842
Shariatpanahi et al., 2010Shariatpanahi, Z. V., Taleban, F. A., Mokhtari, M., &Shahbazi, S. (2010).
Ginger extract reduces delayed gastric emptying and nosocomial pneumonia in adult respiratory distress syndrome patients hospitalized in an intensive care unit.
Journal of critical care, 25(4), 647–650. https://doi.org/10.1016/j.jcrc.2009.12.008
Sarkar & Das, 2021 Sarkar, P. K., & Das Mukhopadhyay, C. (2021).
Ayurvedic metal nanoparticles could be novel antiviral agents against SARS-CoV-2.
International nano letters, 11(3), 197–203. https://doi.org/10.1007/s40089-020-00323-9
Allawadhi et al., 2021 Allawadhi, P., Singh, V., Khurana, A., Khurana, I., Allwadhi, S., Kumar, P., Banothu, A. K., Thalugula, S., Barani, P. J., Naik, R. R., &Bharani, K. K. (2021).
Silver nanoparticle based multifunctional approach for combating COVID-19.
Sensors international, 2, 100101. https://doi.org/10.1016/j.sintl.2021.100101
Furst et al., 1977 Furst, D. E., Levine, S., Srinivasan, R., Metzger, A. L., Bangert, R., & Paulus, H. E. (1977).
A double-blind trial of high versus conventional dosages of gold salts for rheumatoid arthritis.
Arthritis and rheumatism, 20(8), 1473–1480. https://doi.org/10.1002/art.1780200805
Murphy et al., 2012 Murphy, K., Travers, P., Walport, M. & Janeway, C. , (Garland Science, 2012)
Janeway's immunobiology. 8th edn
Meidaninikjeh at al., 2021 Meidaninikjeh, S., Sabouni, N., Marzouni, H. Z., Bengar, S., Khalili, A., & Jafari, R. (2021). Monocytes and macrophages in COVID-19: Friends and foes. Life sciences, 269, 119010. https://doi.org/10.1016/j.lfs.2020.119010
Zeller et al., 2021 Zeller, J., Bogner, B., Kiefer, J., Braig, D., Winninger, O., Fricke, M., Karasu, E., Peter, K., Huber-Lang, M., & Eisenhardt, S. U. (2021).
CRP Enhances the Innate Killing Mechanisms Phagocytosis and ROS Formation in a Conformation and Complement-Dependent Manner.
Frontiers in immunology, 12, 721887. https://doi.org/10.3389/fimmu.2021.721887